[1]
Friedmann, PhD, MD, N., Marsman, PharmD, M.R., de Kater, PhD, A.W., Burns, PhD, L.H. and Webster, MD, L.R. 2018. A nasal abuse potential randomized clinical trial of REMOXY® ER, a high-viscosity extended-release oxycodone formulation. Journal of Opioid Management. 14, 6 (Nov. 2018), 437–443. DOI:https://doi.org/10.5055/jom.2018.0476.